Afatinib-A targeted therapy
Created 4 weeks ago by marykudro

Afatinib is a targeted therapy that is helpful in the treatment of metastatic non-small cell lung cancer (NSCLC). It is classified as a Tyrosine Kinase inhibitor. It comes in the form of a pill and is taken by mouth.Take this medicine on an empty stomach at least 1 hour before or 2 hours after the meal. Swallow the whole tablet with water. Do not crush or chew the tablet. Avoid taking an overdose if you have missed the dose. For any changes in the dose, consult your healthcare professional. Some common side effects of afatinib are Dry mouth, Mouth sores, Decreased appetite, Weight loss, and fever. Afatinib price varies depending upon the different wholesalers and brands.